| Year | Journal | Cohort | Result |
|---|---|---|---|
| 2020 | Oncotarget | 21 profiled and 20 confirmatory | Circulating mRNA transcriptome detectable; >19,000 protein-coding genes represented |
| 2022 | Frontiers in Oncology | 14 HCC, 8 cirrhosis, 6 controls | 5,480 high-risk tumour-specific mRNA variants found in circulation |
| 2025 | Liver Cancer | 50 HCC, 35 cirrhosis, 11 tumours | A 36-variant subset identified every HCC patient in the cohort |
“Panels are not cumulative across studies: the 2022 study reported 5,480 variants; the 2025 panel tested 288.”
